Bipartisan support growing for federal bioeconomy policies

Even as Republicans and Democrats clash over hot button biomedical policy issues from vaccines to NIH funding, a consensus is emerging behind the scenes about the need for the federal government to take action to bolster the competitiveness of the U.S. bioeconomy.

Sen. Todd Young (R-Ind.), chair of the National Security Commission on Emerging Biotechnology (NSCEB), is urging his colleagues and the Trump administration to act urgently on the commission’s recommendations that aim to support the U.S. life sciences sector. ...